학술논문
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial
Document Type
Article
Author
Bunupuradah, Torsak; Kiertiburanakul, Sasisopin; Avihingsanon, Anchalee; Chetchotisakd, Ploenchan; Techapornroong, Malee; Leerattanapetch, Niramon; Kantipong, Pacharee; Bowonwatanuwong, Chureeratana; Banchongkit, Sukit; Klinbuayaem, Virat; Mekviwattanawong, Sripetcharat; Nimitvilai, Sireethorn; Jirajariyavej, Supunnee; Prasithsirikul, Wisit; Munsakul, Warangkana; Bhakeecheep, Sorakij; Chaivooth, Suchada; Phanuphak, Praphan; Cooper, David A; Apornpong, Tanakorn; Kerr, Stephen J; Emery, Sean; Ruxrungtham, Kiat
Source
In The Lancet HIV August 2016 3(8):e343-e350
Subject
Language
ISSN
2352-3018